Scale -


  • Revenue is 2124 Rs Cr; Annual Growth is 15 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 26 %
  • Ebitda is 990 Rs Cr; Annual Growth is 31 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 25 %
  • PBT is 145 Rs Cr; Annual Growth is 25 %; in Top Quartile; 5 Year CAGR is 18 %
  • PAT is 592 Rs Cr; Annual Growth is 31 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 15 %
  • Quarterly Ebitda is 151 Rs Cr; in Top Quartile

Profitability -


  • PBDIT Margin is 46.58 %; Annual Growth is 14 %; Continuous Growth over 3 years; in Top Quartile
  • PAT Margin is 27.85 %; Annual Growth is 14 %; in Top Quartile; 5 Year CAGR is -9 %
  • Quarterly Ebitda Margin is 36 %; in Top Quartile
  • Quarterly Profit margin is 29 %; in Top Quartile

Return -


  • ROCE is 27.56 %; Continuous Growth over 3 years; in Top Quartile
  • ROA is 17.25 %; Continuous Growth over 3 years; in Top Quartile
  • ROE is 19.45 %; in Top Quartile
  • Asset Turnover is 68 %; in Top Quartile

Efficiency -


  • Inventory Turnover Ratio is 9.14; Annual Growth is 37 %
  • Operating cash flow is 844 Rs Cr; Annual Growth is 102 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 40 %
  • Current Ratio is 5.54; Continuous Growth over 3 years; in Top Quartile
  • Quick Ratio is 5.15; Continuous Growth over 3 years; in Top Quartile

Solvancy -


  • Debt/Equity is 0.02; Annual Decline is -60 %; Continuous Decline over 3 years; 5 Year CAGR is -34 %
  • Long term Debt is 27.73 Rs Cr; Annual Decline is -41 %; Continuous Decline over 3 years; 5 Year CAGR is -34 %
  • Total Debt is 51.06 Rs Cr; Annual Decline is -53 %; Continuous Decline over 3 years; 5 Year CAGR is -26 %
  • Contingent Liabilities is 541 Rs Cr; Annual Growth is 154 %; in Top Quartile

Quality -


  • Operating cashflow/ebitda is 85 %; Annual Growth is 54 %; Continuous Growth over 3 years
  • Operating cashflow/PAT is 143 %; Annual Growth is 54 %; Continuous Growth over 3 years; 5 Year CAGR is 22 %
  • Exceptional Items/PBT is -3 %; in Bottom Quartile
  • Other Expenses/Total Expenses is 14 %; in Bottom Quartile; Continuous Growth over 3 years
  • Change in Inventories/Total Expenses is 7 %; Annual Growth is 201 %; in Top Quartile
  • Current Tax/PAT is 41 %; Continuous Growth over 3 years; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Anthem Biosciences (NSEI:ANTHEM) Stock Price